Search for: "Dow v. L & R" Results 61 - 80 of 151
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Dec 2017, 2:18 pm by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
21 Oct 2017, 9:00 am by W.F. Casey Ebsary, Jr.
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]
19 Jul 2021, 5:10 pm by Eugene Volokh
Douglas Div., 570 F.2d 742, 747 (8th Cir. 1978); Sheet Metal Workers Int'l Ass'n v. [read post]
8 Apr 2024, 10:08 am by admin
The immunogenic mechanism had a few lines of potential support, with the most prominent at the time coming from the laboratories of Douglas Radford Shanklin, and his colleague, David L. [read post]
15 May 2014, 9:36 am by Matthew A. Reed
Metabolife Int’l, Inc., 401 F.3d 1233, 1252 (11th Cir. 2005); Tamraz v. [read post]
29 Mar 2021, 7:10 pm by admin
Although no rule or statute prohibits side switching, state and federal courts have exercised what they have called an inherent power to supervise and control ethical breaches by lawyers and expert witnesses.[1] The Wang Test Although certainly not the first case on side-switching, the decision of a federal trial court, in Wang Laboratories, Inc. v Toshiba Corp., has become a key precedent on disqualification of expert witnesses.[2] The test spelled out in the Wang case has generally been… [read post]